Bruno Scheller

Bruno Scheller

Interventional cardiologist / Cardiologist
Saarland University - Homburg, Germany

Latest contributions

The next frontier of DCB is to simplify complexity

29 May 2026

Register for free to this webinar on Monday 29 June at 5:00pm with F. Ribichini and A. Monayer, B. Scheller, P. Suwannasom and learn how to understand the role and potential advantages of DCBs in complex patients and lesions, and much more! ...

DCB: what we know and what we do not know

22 May 2026 – From EuroPCR 2026

This session provides a detailed update on drug-coated balloons (DCB) in interventional cardiology, covering the latest clinical data and trials. It identifies scenarios where DCB use is most effective and offers guidance on optimizing procedural techniques to enhance clinical outcomes.

Is DCB the new gold standard for side branch treatment in bifurcation?

21 May 2026 – From EuroPCR 2026

This session explores the emerging role of drug-coated balloons (DCB) as a potential new standard for side branch treatment in bifurcation lesions. It focuses on selecting appropriate indications, optimal vessel preparation and delivery timing, and executing stepwise DCB strategies versus hybrid approaches to maximize clinical outcomes.

Back to the future - Lessons from the past that can guide contemporary practice

20 May 2026 – From EuroPCR 2026

Reflecting on historical perspectives in the management of atherosclerotic coronary vascular disease, this session imparts valuable lessons to guide contemporary PCI practice. It emphasizes best practices in vessel preparation, evaluates the significance of drug-eluting stents, and provides a pathologist’s insight into mechanisms of PCI failure to...

Intracoronary imaging to guided DCB PCI

20 May 2026 – From EuroPCR 2026

This session highlights the role of intracoronary imaging techniques such as OCT and IVUS in guiding drug-coated balloon (DCB) PCI. It explores novel imaging-guided algorithms for complex bifurcations, prediction of drug-eluting balloon failure, management of calcified nodules, re-entry into true lumen during CTO, and tackling aneurysms...

DCB in contemporary PCI: evidence, technique and physiology-guided decision-making

19 May 2026 – From EuroPCR 2026

This EuroPCR 2026 session explores the evolving role of drug-coated balloons (DCB) in contemporary PCI, highlighting how growing clinical evidence, refined procedural strategies and physiology-guided tools are reshaping everyday practice.

The discussion reviews the latest data supporting DCB use, including long-term outcomes from major registries and trials...

DCB in contemporary PCI: evidence, technique and physiology-guided decision-making

Evolving bifurcation treatment practices: DCB, angio-based FFR and side branch optimisation

19 May 2026 – From EuroPCR 2026

This EuroPCR 2026 session explores the evolving landscape of bifurcation PCI, focusing on drug-coated balloon (DCB) strategies, angio-based fractional flow reserve (FFR) and side branch optimisation. It highlights how new evidence and physiology-guided tools are reshaping decision-making in this complex lesion subset.

Discussions include insights from the...

Evolving bifurcation treatment practices: DCB, angio-based FFR and side branch optimisation

How to use DCB in coronary bifurcations

07 Jul 2025

Watch the replay of this webinar to learn more about the evidence supporting the use of DCB in the treatment of coronary bifurcations, and much more!

Which device for which patient: DES, BRS or DCB?

22 May 2025 – From EuroPCR 2025

This session provides comprehensive guidance on selecting the appropriate device—DES, BRS, or DCB—for individual patients and lesions. It examines patient and lesion characteristics, strengths and limitations of each device type, and regional considerations, illustrated by case presentations demonstrating practical device choice and resolution.

Which device for which patient: DES, BRS or DCB?

Is DCB a new valid option for coronary revascularisation?

22 May 2025 – From EuroPCR 2025

This session provides an in-depth evaluation of drug-coated balloons (DCB) as a valid option for coronary revascularisation. Topics include two-year follow-up comparisons between paclitaxel and sirolimus-coated balloons, clinical outcomes after bailout stenting post-DCB angioplasty, meta-analyses contrasting DCB and DES for large native coronary artery disease, and...

Is DCB a new valid option for coronary revascularisation?

Current DCB practice: from lesion preparation to follow-up

21 May 2025 – From EuroPCR 2025

Explore current best practices in drug-coated balloon (DCB) angioplasty from lesion preparation to follow-up. This session discusses common indications, management of dissections and complications, and shares practical tips and case examples, equipping clinicians with comprehensive knowledge to optimize DCB use in contemporary PCI.

Current DCB practice: from lesion preparation to follow-up

DCB in challenging scenarios - Part 1

21 May 2025 – From EuroPCR 2025

Discover the expanding role of drug-coated balloons (DCB) in challenging coronary interventions. This session covers their application in acute coronary syndrome complications, complex coronary artery disease revascularization, and in-stent restenosis at left main bifurcations, highlighting innovative combinations with drug-eluting stents for managing complex bifurcation and trifurcation...

DCB in challenging scenarios - Part 1

How do I confidently expand my drug-coated balloon practice?

21 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session challenges the conventional approach to bifurcation PCI and dissection management. Learn why drug-coated balloons (DCB) may offer better long-term outcomes in cases where stents fall short, how DCBs can simplify bifurcation strategies, and why it’s time to rethink which dissections really need...

How do I confidently expand my drug-coated balloon practice?

From theory to practice: the versatility of drug-coated balloons around the world

20 May 2025 – From EuroPCR 2025

Step into the world of drug-coated balloons (DCBs) with this EuroPCR 2025 session, tracing their journey from pioneering use in Europe to versatile applications worldwide. Discover the latest evidence on the safety and efficacy of both paclitaxel- and sirolimus-coated balloons across diverse lesion types—from straightforward to...

From theory to practice: the versatility of drug-coated balloons around the world

What is the latest in DCB practice?

21 May 2025 – From EuroPCR 2025

Robert Byrne and Bruno Scheller explore the current role of drug-coated balloon (DCB) angioplasty nearly two decades after its initial clinical use. This discussion covers when and how to apply DCB angioplasty effectively in everyday practice, focusing on lesion preparation for de novo coronary disease and...

What is the latest in DCB practice?

Stent or Leave: considerations for a successful DCB PCI

27 Feb 2025

Watch the replay webinar with F. Ribichini, F. Jafary, Y. Onuma and B. Scheller to learn how to “control” dissections during lesion preparation, and much more!

Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions

08 Jan 2025

In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.

Author

Bruno Scheller

DCB digital crosstalk: practice patterns for patients with diabetes and diffuse disease in Asia

16 Oct 2024

Watch the replay of this webinar on the concept of DCB in native vessel disease and so much more!

DCB digital crosstalk: practice patterns for patients with diabetes and diffuse disease in Europe

07 Oct 2024

Watch the replay of this webinar on the concept of DCB in native vessel disease and so much more!

A patient with ISR: what is the role of DCB today?

07 Oct 2024

Watch the replay of this webinar to review the mechanisms of ISR and so much more!

Drug-coated balloons as a first choice for patients with de novo lesions: pros and cons

25 Sep 2024

Watch the replay of this webinar about the concept of DCB in native vessel disease and so much more!

Stentless bifurcation PCI: what does the future hold?

25 Sep 2024

Watch the replay of this webinar on contemporary challenges in bifurcation PCI in case examples and so much more!

Mastering the future of PCI with drug-coated balloons

16 May 2024 – From EuroPCR 2024

Join this session dedicated to drug-coated balloons (DCB) to delve into the evolution of angioplasty with DCBs in the U.S. Learn about the established standard of care, balancing efficacy and safety in treating in-stent restenosis (ISR). Gain insights into the fundamental principles of angioplasty with DCB...

Mastering the future of PCI with drug-coated balloons

Imaging-guided PCI for stent failure - LIVE case

16 May 2024 – From EuroPCR 2024

An 86-year-old male with PAD, a stroke in 2007, and a history of LAD PCI in 2006, presented with unstable angina due to LAD stent restenosis involving D1 and D2, with preserved LV function.
Guided by OCT, the operators performed stenosis preparation using IVL, treated the distal...

Imaging-guided PCI for stent failure - LIVE case

The ARC consensus on DCB - evidence-based DCB technology

15 May 2024 – From EuroPCR 2024

In this replay, discover why DCBs are essential in treating de novo CAD, the importance of optimal lesion preparation for long-term success, and how future trials will focus on treatment strategies rather than device comparisons, highlighting the need for further research.

Evidence-based on DCB technology that have dictated the ARC consensus on DCB

How do I confidently expand my DCB practice?

15 May 2024 – From EuroPCR 2024

This session offers insights on identifying appropriate lesions for DCB treatment, understanding the essential concepts for achieving optimal immediate results with DCB PCI, and exploring the long-term angiographic and clinical outcomes. The session emphasizes the importance of lesion preparation, notes that there are no contraindications for...

How do I confidently expand my DCB practice?

DCB PCI for de novo lesions: when and how?

15 May 2024 – From EuroPCR 2024

In this session, you will learn how to optimally perform DCB PCI, identify which lesions are best suited for this approach, and understand when it's necessary to switch from DCB to stent PCI. The session also features a debate on whether DCB-PCI should be the first...

DCB PCI for de novo lesions: when and how?

Bioresorbable scaffolds - new evidence and clinical applications

09 May 2024

Watch this webinar with M. Haude, H. Garcia Garcia, M. Joner and B. Scheller on how to revisit the concept and new technology of BRS and much more!

Why and when to use DCB?

06 Mar 2024

Watch the replay of this webinar to discuss why a PCI strategy without implantation of metallic stents may be a valid alternative and wich is the supporting evidence.